Skip to main content
Signal8

LEDGER STEVEN A

SEC insider (Form 3/4/5 filer). CIK 0001090206. Chief Executive Officer at Serina Therapeutics, Inc. (SER). 5 reported Form 4/5 transactions since Sep 2024; latest on May 26, 2026. Located in HUNTSVILLE, AL.

Companies LEDGER STEVEN A has filed insider reports for

  • Serina Therapeutics, Inc. (SER): Director, Officer, Chief Executive Officer
LEDGER STEVEN A profile photo

LEDGER STEVEN A

CIK: 0001090206

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (80.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (20.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Serina Therapeutics, Inc. logo
SER

Serina Therapeutics, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Serina Therapeutics, Inc. logo
    SER

    Serina Therapeutics, Inc.

    May 26, 2026
    Award
    Direct
    10.1K shares at avg. $1.93$19K
  • Serina Therapeutics, Inc. logo
    SER

    Serina Therapeutics, Inc.

    May 21, 2026
    Award

    Stock Option (right to buy)

    Direct
    380.8K shares-
  • Serina Therapeutics, Inc. logo
    SER

    Serina Therapeutics, Inc.

    Feb 3, 2026
    Award

    Stock Option (right to buy)

    Direct
    230.1K shares-
  • Serina Therapeutics, Inc. logo
    SER

    Serina Therapeutics, Inc.

    Mar 28, 2025
    Other
    Direct
    95.7K shares-
  • Serina Therapeutics, Inc. logo
    SER

    Serina Therapeutics, Inc.

    Sep 9, 2024
    Award

    Stock Option (right to buy)

    Direct
    376.4K shares-

1-5 of 5